Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Stephen J. Russell David Dingli Ronald S Go Morie A Gertz Angela Dispenzieri Martha Q Lacy S. Vincent Rajkumar Francis K Buadi Suzanne R Hayman Prashant Kapoor Yi Lisa Hwa Robert A Kyle Shaji K Kumar Steven R Zeldenrust Martha Grogan |
| Publication date | April 2, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |